A lutein and zeaxanthin supplement must be specified in terms of both label claim and raw-material input. The required input weight depends on the ingredient’s chemical form, assay basis, and confirmed specification. Dosage-form compatibility and finished-product testing belong in that same specification, which is what lutein supplement manufacturing quotes.
KS Nutripharma supports OEM, ODM, and private-label development using marigold-derived lutein ingredients. This guide covers raw-material selection, label-claim calculations, dosage-form feasibility, and the quality evidence needed to support a finished-product specification.
The amounts shown are commercial formulation examples for product development and quotation purposes, not recommended daily intakes.
Lutein and Zeaxanthin Raw Material Specifications
The grades below are the ones listed in the marigold-derived lutein ingredient specifications. They are catalog listings. They are not a statement that every grade is available for every project.
Ingredient form | Assay grades listed in the referenced catalog | Analytical method listed |
|---|---|---|
| Lutein powder | 5%, 10%, 20%, 60%, 80% | UV or HPLC, depending on grade |
| Lutein micro-capsule | 5%, 10%, 20% | UV or HPLC, depending on grade |
| Lutein oil | 10%, 20% | UV or HPLC, depending on grade |
| Lutein ester powder | 5%, 10%, 20%, 60% | UV or HPLC, depending on grade |
| Lutein ester oil | 10%, 20%; sunflower-oil carrier listed | UV or HPLC, depending on grade |
| Zeaxanthin powder | 5%, 10%, 20%, 60% | HPLC |
| Zeaxanthin micro-capsule | 5% | HPLC |
| Zeaxanthin oil | 10%, 20% | HPLC |
These are the assay grades and analytical methods listed in the referenced ingredient catalog, not a guarantee that every grade is available for every project. Confirm the current specification, chemical form, assay basis, analytical method, carrier, and supply availability before quotation. Where a catalog lists UV or HPLC, the method applicable to the selected grade and lot must be stated in the approved specification. A UV result and an HPLC result are not treated as interchangeable. The specification limit and a single lot’s result are also different numbers. Particle size and bulk density are quoted only when that specification states them.
The catalog name for the encapsulated powder is micro-capsule. CWS, CWD, and beadlet are not other names for that line. Each term is used only as the supplier defines it for that grade.
Free Lutein and Lutein Esters
Marigold flowers contain lutein esters. Free lutein can be prepared from those esters, including by saponification. The commercial grade is defined by its specification, not by assuming one preparation route for every lot.
The ingredient specification, assay calculation, and finished-product label must use consistent terminology for free lutein, lutein esters, or a stated lutein equivalent. The applicable declaration depends on the ingredient actually used and the labeling requirements of the destination market. Do not calculate an ester ingredient on a free-lutein basis unless the supplier specification defines and supports that conversion.
Esters carry fatty-acid groups, so an ester weight is not the same figure as the lutein it corresponds to. Two documents that both print “20%” describe the same ingredient only when both name the chemical form and the method.
Zeaxanthin Content and Ingredient Selection
The specification identifies whether zeaxanthin is contributed by the selected lutein ingredient, supplied separately, or both. Any contribution from the lutein ingredient is included in the formulation calculation only when its amount and assay basis are documented and suitable for that purpose. The approved bill of materials records each source and the calculation used to support the finished-product claim. Meso-zeaxanthin is included only when the bill of materials names it.
Assay Basis, Analytical Methods, and Compendial Requirements
A supplier assay result and USP compendial compliance are separate questions. When a project requires USP compliance, verify the applicable monograph, ingredient definition, assay basis, acceptance criteria, and required methods against the selected ingredient and its supporting documentation. An HPLC result alone does not establish compendial compliance.
How to Calculate Lutein and Zeaxanthin Input Weights
Theoretical ingredient weight is the declared milligrams divided by the confirmed assay, expressed as a decimal. The assay and the declaration have to use the same chemical form.
For a free-lutein grade, the arithmetic is direct. A 10 mg lutein declaration from a 20% free-lutein ingredient, on the same weight basis, requires 50 mg of that ingredient. A 20 mg declaration from the same grade requires 100 mg. A 2 mg zeaxanthin declaration from a 20% zeaxanthin grade requires 10 mg of that grade, and only when that zeaxanthin is being added rather than already counted, on a documented basis, inside the lutein grade.
Ester example, for one confirmed specification. If that specification states that a 20% lutein ester ingredient provides a 10% lutein equivalent on the same stated weight basis, a 10 mg lutein-equivalent declaration would theoretically require 100 mg of that ingredient before any process adjustment a trial has measured. The 100 mg figure is not reused for an ester whose specification does not define that conversion.
A 20% free-lutein oil and a 20% ester oil are different fill weights even when both documents print “20%.” Process loss sits outside the theoretical weight. A softgel fill, a tablet press, and a gummy cook do not lose the same fraction, and none of those fractions is assumed in the quotation.
A two-capsule serving of 10 mg in each capsule is a 20 mg serving made from two units. A single capsule declared at 20 mg is one heavier unit. The serving size and the fill weight have to name which one it is.
Lutein and Zeaxanthin Formula Design Options
AREDS2 studied lutein at 10 mg and zeaxanthin at 2 mg as an added carotenoid pair. Participants also received the original AREDS formulation or a variant of it. The original AREDS formulation contained vitamin C 500 mg, vitamin E 400 IU, beta-carotene 15 mg, zinc 80 mg, and copper 2 mg. The AREDS2 design also tested variants without beta-carotene and with a lower zinc dose. [1][2]
The 10 mg and 2 mg pair is a reference point for commercial specifications. It is not a universal intake, and it is not, by itself, a complete AREDS or AREDS2 formula. A project built on an AREDS2-style nutrient profile needs a separate check of the selected nutrients, the ingredient forms, the label claims, and the destination market. Zinc at 80 mg and zinc at the lower study dose are different study arms.
10 mg Lutein + 2 mg Zeaxanthin
Use when: The brief names both carotenoids at this pair.
Specify: Declared lutein amount and calculation basis, zeaxanthin milligrams, and whether zeaxanthin comes from the lutein grade, a separate grade, or both. Input weight comes from the calculation above.
Trade-off: A second carotenoid line, against a lutein-only declaration. The pair does not include vitamin C, vitamin E, zinc, or copper.
Higher-Strength Formulas
Use when: The brief specifies a 20 mg lutein and 4 mg zeaxanthin declaration, and the selected dosage form can hold the ingredient input.
Specify: The same assay basis as the 10 mg + 2 mg brief, then the higher fill weight or a two-unit serving.
Trade-off: More carotenoid mass, which may mean a larger fill or two units. A higher declaration is a commercial specification. It is not a more suitable dose.
Lutein-Only Formulas
Use when: The product is developed without a separate zeaxanthin claim.
Specify: Declared lutein amount and calculation basis. If the selected lutein ingredient contains zeaxanthin, that amount is documented when the specification gives an assay basis suitable for the calculation. Whether the panel declares it is reviewed against the destination market.
Trade-off: One declared carotenoid. A 40 mg lutein declaration is checked as fill weight, and often becomes two units.
Additional Carotenoids, Oils, and Botanicals
Use when: Astaxanthin, DHA, EPA, or a dry botanical is on the panel with lutein and zeaxanthin.
Specify: Each amount on its own line. Astaxanthin in a shared oil is named in the astaxanthin supplement file. DHA and EPA amounts, and the oil’s peroxide value, are named in the DHA supplement file. A dry botanical such as bilberry is named by identity and marker in the bilberry supplement file.
Trade-off: Astaxanthin or a marine or algal oil can share the carotenoid fill, and that fill gets heavier. A dry botanical does not dissolve into that oil. It is assessed for a capsule, or for a gummy only after the carotenoid grade is qualified in the cook. A three-carotenoid comparison is specified in the lutein, zeaxanthin, and astaxanthin formulation guide.
Choosing a Dosage Form for Lutein and Zeaxanthin
A listed form is a candidate. It is qualified only after the trial for that process. CWS, CWD, beadlet, and micro-capsule stay distinct. A brief that says “water-soluble lutein” is clarified first: dissolution, dispersion, or a named micro-capsule grade.
Dosage form | Candidate ingredient form | Confirm before the trial | Main development risk |
|---|---|---|---|
| Softgels | Oil of free lutein or lutein ester | Assay basis, carrier oil, fill weight, suspension uniformity | Fill consistency, oxidation, and whether the pack matches that oil |
| Hard capsules | A powder, beadlet, or micro-capsule qualified for dry fill | Assay, flow, fill weight, capsule size | Fill weight, blend uniformity, finished-unit assay |
| Tablets | A powder or beadlet qualified for the press | Compression behavior, content uniformity, excipient compatibility | Effect of compression on the particle and on the assay |
| Gummies | A grade qualified by a cook trial | Assay before and after the cook, color uniformity, dispersion, water activity | Process loss, matrix compatibility, shelf life of the piece |
| Powders and stick packs | A grade qualified for the blend or the drink | Moisture, dispersion, carrier, barrier film | Blend uniformity, moisture uptake, and protection by the pack |
Softgels
Viscosity and the fill assay are checked before the fill size is confirmed. Shell opacity and headspace oxygen are chosen for that oil. A sealed shell shows that the softgel closed. It does not replace stability data.
Hard Capsules and Tablets
A capsule uses the powder, beadlet, or micro-capsule named for dry fill. An oil suspension is a different ingredient. A tablet is where a press-compatible solid belongs, including minerals that will not fit in the carotenoid oil. The beadlet still has to pass the press that will be used.
Gummies
The cook is hot and the piece holds water. The serving may be more than one piece, and that count is part of the declaration. A formulation scenario, not a customer project: a brief that starts on an unprotected ester powder can show uneven color, an assay after the cook below the incoming result, and variation from piece to piece. The grade is then run through the same cook. The figures compared with the declaration are the piece assay after the cook and, later, the piece assay in the commercial pack. No loss percentage is assumed before that trial.
Powders and Stick Packs
A stick, a sachet, or a drink uses a grade qualified for that blend. The result that matters is the labeled serving after dispersion, not the drum assay. A softgel oil is not that blend.
Finished-Product Stability, Packaging, and Testing
Lutein and zeaxanthin stability is evaluated for the ingredient form, the finished formula, the process, and the commercial pack together. Light, oxygen, heat, and moisture may affect quality. How much each one matters depends on the dosage form and the storage conditions.
Incoming assay, release testing, and stability testing do different jobs. The incoming result qualifies the ingredient lot. Release testing compares the finished unit with its approved specification. A stability study asks whether that unit, in the pack that will ship, still meets the defined criteria over the proposed storage period.
Light protection, an oxygen barrier, a closure, or a desiccant is chosen for the risks identified for that product. Accelerated storage can show a weak grade or a weak pack early. The date printed on the label is the one the stability program and the applicable market rules support. A raw-material storage period is not the finished product’s shelf life.
When the formula, the pack, or the process changes, the risk assessment decides whether extra verification is enough or whether the stability study has to be repeated.
Quality Documentation and Batch Release
Finished-product release tests are defined by the approved product specification, dosage form, target market, risk assessment, and quality agreement. Depending on the product, they may include appearance, unit-weight controls, content uniformity, lutein or zeaxanthin assay, microbiological limits, and specified contaminant tests. The applicable methods, acceptance criteria, and testing responsibility are agreed before production.
The brand receives the agreed specification, the raw-material lot certificate, and the finished-product release certificate. A stability report is included when the agreement names the pack and the time points. Production runs in cGMP workshops.
Manufacturing Feasibility, MOQ, and Lead Time at KS Nutripharma
Lutein supplement manufacturing is where the finished specification is quoted. Planning estimates used for current projects are about 3,000–5,000 bottles for a softgel or capsule project and about 5,000–10,000 bottles for a gummy project. Lead time is typically 4–8 weeks after the formula and the artwork are locked. Both figures are confirmed against the production rule in force for that formula and pack before the quotation is issued. A cook trial, a two-unit serving, a shared oil, or a new barrier pack can move the estimate.
The quotation also states which sample is included. That may be a formulation or laboratory sample, or a unit in the proposed pack. The guide does not assign one of those by default.
A comparable quotation needs:
- Target market and finished-product label claim
- Serving size and units per serving
- Lutein form, assay basis, and zeaxanthin source
- Preferred dosage form and packaging
- Any formula sheet, raw-material specification, or reference label already available
Send Your Lutein and Zeaxanthin Specification for a Feasibility Review
From Product Brief to Finished Batch
- Lock the declared amounts, the calculation basis, and the serving size.
- Match the grade and record each zeaxanthin source.
- Calculate the theoretical input, then add process loss only from a measured trial.
- Run the trial for that grade: softgel fill, capsule fill, tablet compression, gummy cook, or stick dispersion.
- Release the finished unit against the agreed tests, and study the commercial pack when the agreement names that study.
Frequently Asked Questions
How is lutein input weight calculated from the assay?
Divide the declared milligrams by the confirmed assay, written as a decimal, on the same chemical form. A 10 mg declaration from 20% free lutein is 50 mg of that ingredient. An ester uses only the lutein equivalent that grade’s specification defines.
What is the difference between free lutein and lutein esters?
Free lutein can be prepared from lutein esters. An ester percentage includes the fatty-acid portion, so it is not automatically a free-lutein percentage. The specification, the calculation, and the finished label have to use the same term, and the destination market sets the declaration.
What information is needed to quote a lutein and zeaxanthin formula?
The market and label claim, the serving, the lutein form and zeaxanthin source, the dosage form and pack, and any formula sheet, specification, or reference label already in hand. A target strength and a format can open the file. The missing items are what the feasibility review marks.
Technical and Regulatory References
- National Institutes of Health, Office of Dietary Supplements. Vitamin A and Carotenoids — Health Professional Fact Sheet. https://ods.od.nih.gov/factsheets/VitaminA-HealthProfessional/
- Age-Related Eye Disease Study 2 (AREDS2) Research Group. Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration: The AREDS2 Randomized Clinical Trial. JAMA. 2013;309(19):2005-2015. https://doi.org/10.1001/jama.2013.4997
Related
Disclaimer
KS Nutripharma manufactures dietary supplements for brand owners. Amounts on this page are commercial formulation examples for quotation, not recommended intakes. AREDS and AREDS2 descriptions are research context for development. They are not a license to claim treatment, prevention, or restoration of vision, including age-related macular degeneration, and they are not a finished formula to copy. Order quantities and lead times are planning estimates until the quotation confirms them. KS confirms the specification it manufactures and the tests named in the quality agreement. The brand owner confirms the finished label and the market rules for that ingredient.
Written by KS Nutripharma Formulation Team | Reviewed by KS Nutripharma Director of R&D (PhD, Food Science | 19+ years nutraceutical development) | Technical review scope: catalog grades versus a confirmed specification; free lutein versus lutein ester only where the specification defines the conversion; release tests set by the quality agreement | Updated October 2026
Team background: KS Nutripharma
